Advertisement
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: a case-control test-negative design study

October 23, 2020

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: a case-control test-negative design study

Hannah Lawrence and colleagues assess the long-term vaccine effectiveness of PPV23 in adults in the setting of an established childhood pneumococcal vaccine program.

Image credit: ZaldyImg, Flickr

Call for Papers: Early Detection and Minimal Residual Disease

We invite high quality studies addressing this topic. Submission deadline: 15 March 2021.

Read more and submit!

Get new content from PLOS Medicine in your inbox

Thank you! You have successfully subscribed to the PLOS Medicine newsletter.

Sorry, an error occurred while sending your subscription. Please try again later.

Try again